Latest Industry Projects

Our List of Pharmaceutical Projects helps to drive insights-driven action and Pharma execution for superior ROI and they include Pharmaceutical Industry Featured Projects, Upcoming Projects in Pharmaceutical and so on. We provide Global Pharmaceuticals Industry Projects to our clients to ensure efficiencies and effectiveness in their business efforts. Moreover, Pharmaceutical Industry projects leverage cross-channel integration to engage the consumers, generate insights, and measure business value.

Sterling Pharma Solutions to Invest US$8 million in Pilot Plant Facility at its UK Site

Introduction: Contract Development and Manufacturing Organisation (CDMO), Sterling Pharma Solutions is investing US$8 million into its pilot plant facility at its UK site. Features: The facility will enhance the pilot plant’s capacity by 33 per cent and increase the site’s production capabilities and flexibility for small to mid-scale batch production.…

Ferring Announces US$30 million Expansion Plan of New Biotech Centre in Switzerland

Introduction: Ferring Pharmaceuticals made a US$30 million investment announcement of expanding its capabilities in biologics through a new biotech centre at its global headquarters and manufacturing site in St Prex, Switzerland. Features: Ferring Pharmaceuticals is planning to integrate discovery and development capabilities for monoclonal antibodies as well as biologics manufacturing…

Sangamo Plans For New Headquarters In Brisbane, California

Introduction: Sangamo Therapeutics, Inc. plans for new corporate headquarters at 7000 Marina Boulevard, an 88,000 square foot building at Oyster Point in Brisbane, California, in the heart of the biotech hub south of San Francisco. Features: In addition to laboratories, workstations and collaboration spaces, Sangamo will construct on-site in Brisbane…

 Sanofi to invest €170 million in new vaccine production facility in France

Introduction: Sanofi to invest €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion further strengthens Sanofi’s position as one of the world’s leading seasonal flu vaccine providers. Features: The new facility will allow Sanofi Pasteur, the Vaccines global business unit of Sanofi, to expand…

Ventria Bioscience Announces Expansion of Biomanufacturing and Laboratory Facilities

Introduction: Ventria Bioscience Inc. plans for expansion of biomanufacturing and laboratory facilities to roughly double Ventria’s capacity for production of recombinant proteins. Features: The company broke ground on the expansion of its molecular biology lab, greenhouses, process development and analytical lab, and processing capacity in Junction City, Kansas. Ventria’s proprietary…

Kaneka Eurogentec Plans to Construct New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility in Belgium

Introduction: Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO) announced the construction of a new state of-the-art GMP facility. Features: The expansion will allow for the large scale production of biopharmaceuticals including recombinant proteins, antibody fragments and plasmid DNA. The multi-product facility will include…

GSK Plans to Invest More Than £140 Million on UK Manufacturing Network

Introduction: GSK plans to improve the efficiency and competitiveness of its manufacturing network with an investment of £140 Million. Features: These include both investments for respiratory and HIV medicines manufacturing in the UK and strategic reviews, including the sale of several products and a proposal to close a UK manufacturing…

Patheon to invest $45 million in spray drying & manufacturing solutions

Introduction: Patheon N.V., a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical sector plans to invest $45 million at key sites across its global network to meet growing customer demand for expanded service capabilities. Features: As outsourcing of Pharma development and manufacturing services continues to…

GSK to Invest $139 Million to expand production capacity for BENLYSTA (belimumab) in Rockville, Maryland

Introduction: GSK announced $139 million of investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for adult patients with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy. Features: The Rockville site is also expected to house production of a new…

Apotex to Invest $184 Million for Expansion of R&D, Manufacturing, and Packaging Facility in United States

Introduction: Apotex Inc., the largest Canadian owned pharmaceutical company plans $184 million U.S. expansion plan, including the development of a new R&D center and advanced manufacturing and packaging facility that will serve as the U.S. headquarters for Apotex Corp. and the U.S. offices for Apobiologix. Features: The company chose this…

loadmore..